Clinical Trial Update: Efficacy of Nitrous Oxide in OCD: Pilot Study [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial at Stanford University is evaluating nitrous oxide for obsessive-compulsive disorder and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Nitrous oxide (nitrous oxide)

Snippet

Sponsor: Stanford University | Conditions: Obsessive-Compulsive Disorder | Phase 2 | Status: RECRUITING